文献速递运动医学关节外科

围手术期使用他汀类药物的血脂异常与关节镜下肩袖术后24个月功能结局较差无关

Dyslipidemia With Perioperative Statin Usage Is Not Associated With Poorer 24-Month Functional Outcomes After Arthroscopic Rotator Cuff Surgery.
PubMed 文献 · Am J Sports Med · 2020-07-21

该队列研究纳入2010至2016年266例因非创伤性全层撕裂行关节镜下双排肩袖修复的患者,评估血脂异常(DL)及他汀使用对术后功能的影响。结果显示DL组术前CSS和OXF评分较差,但24个月时DL与非DL组评分无显著差异,且DL组CSS和OXF的改善百分比更大;他汀使用者与非使用者24个月功能结局无显著差异。

要点

  • 血脂异常组术前Constant肩关节评分(P=.001)和Oxford肩关节评分(P=.032)较非血脂异常组差。
  • 24个月时血脂异常组与非血脂异常组功能评分无显著差异,但血脂异常组CSS和OXF改善百分比更大(P=.008和P=.034)。
  • 他汀使用者与非使用者24个月功能结局无显著差异,他汀剂量增加与24个月CSS、OXF、UCLASS或VAS变化无统计学显著关联。

核心结论

  • 围手术期使用他汀类药物的血脂异常患者,在关节镜下肩袖术后24个月的功能结局并不比无血脂异常的患者差。

研究设计与样本

  • 队列研究,证据等级3级;2010年至2016年间266例因非创伤性全层撕裂行关节镜下双排肩袖修复的患者。
  • 术前及术后3、6、12、24个月评估Constant肩关节评分(CSS)、Oxford肩关节评分(OXF)、加州大学洛杉矶分校肩关节评分量表(UCLASS)及疼痛视觉模拟量表(VAS)。
  • 通过术前6个月内健康筛查和血脂水平(甘油三酯、总胆固醇、低密度脂蛋白和高密度脂蛋白)评估将患者分为血脂异常组和非血脂异常组,血脂异常组再分为他汀使用者和非使用者。
  • 记录他汀种类和剂量,并采用强度和等效性图表进行标准化;使用Mann-Whitney U检验和Pearson卡方检验分析,采用广义估计方程和线性混合模型分别检验血脂异常和他汀剂量对术后结局评分百分比变化的影响。

主要发现

  • 年龄增加与血脂异常发生率更高相关(P < .001),血脂异常组中86%正在使用他汀。
  • 血脂异常组术前评分较差(CSS,P = .001;OXF,P = .032)。
  • 24个月时血脂异常组与非血脂异常组评分无显著差异。
  • 24个月时血脂异常组CSS和OXF自术前基线的改善百分比大于非血脂异常组(P = .008和P = .034)。
  • 他汀使用者与非使用者24个月功能结局无显著差异;他汀剂量增加时24个月CSS、OXF、UCLASS或VAS无统计学显著变化。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Current literature suggests a higher rate of rotator cuff disease development in patients with dyslipidemia (DL). Moderate to high levels of DL are associated with higher rates of retear and revision surgery after arthroscopic rotator cuff repair. Statins protect against development of rotator cuff disease and mitigate the need for rotator cuff repair. PURPOSE: We aimed to investigate the influence of DL and statin use on postoperative functional outcomes. STUDY DESIGN: Cohort study; Level of evidence, 3. METHODS: Between 2010 and 2016, 266 patients underwent arthroscopic double-row rotator cuff repair for atraumatic full-thickness tears. Evaluation was conducted preoperatively and at 3, 6, 12, and 24 months postoperatively. Three functional outcome measures were used (Constant Shoulder Score [CSS], Oxford Shoulder Score [OXF], and University of California, Los Angeles, Shoulder Rating Scale [UCLASS]), as well as a visual analog scale (VAS) for pain. DL and non-DL were classified through screening of health and assessment of lipid levels within 6 months of surgery (triglycerides, total cholesterol, low-density lipoprotein, and high-density lipoprotein). Patients with DL were divided into statin users and nonusers. Types and dosages of statins were recorded, and intensity and equivalency charts were employed for standardization. Mann-Whitney U test and Pearson chi-square test were used for analysis. Generalized estimating equations and linear mixed models were used to examine the influence of DL and statin dosage, respectively on percentage change of postoperative outcome scores. RESULTS: Increased age was associated with a higher incidence of DL (P < .001), and 86% of the DL group was taking statins. The DL group also exhibited poorer scores preoperatively (CSS, P = .001; OXF, P = .032). No significant difference in scores was elicited between the DL and non-DL groups at 24 months. However, patients with DL experienced greater percentage improvement of CSS and OXF from preoperative baseline than did patients without DL (P = .008 and P = .034, respectively) at 24 months. There was no significant difference in 24-month functional outcomes between statin users and nonusers. No statistically significant change of CSS; OXF; UCLASS; or VAS was noted with increasing statin doses at 24 months. CONCLUSION: Patients with DL with perioperative statin usage did not have poorer 24-month functional outcomes after arthroscopic rotator cuff surgery compared with those in patients without DL.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Zeng GJS, Lee MJH, Chen JY, et al. Dyslipidemia With Perioperative Statin Usage Is Not Associated With Poorer 24-Month Functional Outcomes After Arthroscopic Rotator Cuff Surgery. Am J Sports Med. 2020. PMID: 32692629. doi:10.1177/0363546520937266

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。